OXYCODONE TEVA 10 mg depottabletti Somija - somu - Fimea (Suomen lääkevirasto)

oxycodone teva 10 mg depottabletti

ratiopharm gmbh - oxycodoni hydrochloridum - depottabletti - 10 mg - oksikodoni

OXYCODONE TEVA 15 mg depottabletti Somija - somu - Fimea (Suomen lääkevirasto)

oxycodone teva 15 mg depottabletti

ratiopharm gmbh - oxycodoni hydrochloridum - depottabletti - 15 mg - oksikodoni

OXYCODONE TEVA 20 mg depottabletti Somija - somu - Fimea (Suomen lääkevirasto)

oxycodone teva 20 mg depottabletti

ratiopharm gmbh - oxycodoni hydrochloridum - depottabletti - 20 mg - oksikodoni

OXYCODONE TEVA 40 mg depottabletti Somija - somu - Fimea (Suomen lääkevirasto)

oxycodone teva 40 mg depottabletti

ratiopharm gmbh - oxycodoni hydrochloridum - depottabletti - 40 mg - oksikodoni

OXYCODONE TEVA 60 mg depottabletti Somija - somu - Fimea (Suomen lääkevirasto)

oxycodone teva 60 mg depottabletti

ratiopharm gmbh - oxycodoni hydrochloridum - depottabletti - 60 mg - oksikodoni

OXYCODONE TEVA 80 mg depottabletti Somija - somu - Fimea (Suomen lääkevirasto)

oxycodone teva 80 mg depottabletti

ratiopharm gmbh - oxycodoni hydrochloridum - depottabletti - 80 mg - oksikodoni

OXYCODONE TEVA 30 mg depottabletti Somija - somu - Fimea (Suomen lääkevirasto)

oxycodone teva 30 mg depottabletti

ratiopharm gmbh - oxycodoni hydrochloridum - depottabletti - 30 mg - oksikodoni

Revolade Eiropas Savienība - somu - EMA (European Medicines Agency)

revolade

novartis europharm limited - eltrombopag - purpura, trombosytopeeninen, idiopaattinen - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

Tadex 10 mg tabletti Somija - somu - Fimea (Suomen lääkevirasto)

tadex 10 mg tabletti

orion corporation - tamoxifen citrate - tabletti - 10 mg - tamoksifeeni

Tadex 20 mg tabletti Somija - somu - Fimea (Suomen lääkevirasto)

tadex 20 mg tabletti

orion corporation - tamoxifen citrate - tabletti - 20 mg - tamoksifeeni